Pharmaceuticals, Biotechnology and Life Sciences
The University of Alabama at Birmingham (UAB) and Mereo BioPharma Group plc (NASDAQ: MREO), today announced top-line data from a Phase 1b/2 clinical trial evaluating alvelestat, a novel, orally active...
Pfizer said Wednesday that the results from multiple studies showed the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets), is...
A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-19. The trial, ACTIV-2, is sponsored by the National Institute of Allergy...
Researchers from the National Institutes of Health have identified and tested a drug combination that exploits a weakness in small...
An international team of scientists has found evidence that SARS-CoV-2, the virus that causes COVID-19, infects cells in the mouth....
GUANGZHOU, China–(BUSINESS WIRE)–#AUSTRALIA–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in Phase 1…
STAFFORD, Texas–(BUSINESS WIRE)–Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an…
In the RATIONALE 305 trial, tislelizumab combined with chemotherapy prolonged overall survival for patients with PD-L1 expression Additional follow-up is…
Training programme to be conducted in partnership with industry-leading educational company, Fluence Initiation of training represents key step to incorporate…
MaaT033 is a high-richness, high-diversity, donor-derived Microbiome Ecosystem Therapy for oral administration Four cohorts have completed the study in the…
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the Health Canada approval of Sohonos (palovarotene capsules), an oral…
NEW YORK & MIAMI–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and OPKO Health, Inc. (NASDAQ: OPK) announced today that the U.S. Food…
DUBLIN–(BUSINESS WIRE)–The “Infection Control – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Infection Control…
DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Excipients Market Size, Trends & Growth Opportunity, By product, By Formulations, Region and Forecast to 2027”…
DUBLIN–(BUSINESS WIRE)–The “Antibody Drug Conjugates Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)” report has been added…
